BML (BMLKF) Scaled Net Operating Assets: 0.38 (As of Mar. 2026)


BMLKF BML Inc BMLKF
73 GF Score
Price $25.21
GF Value $26.44
! 2 Warning Signs
View Full Analysis

What is BML Scaled Net Operating Assets?

BML BMLKF 73 Scaled Net Operating Assets is 0.38 as of Mar. 2026. GuruFocus rates BMLKF with a GF Score™ of 73/100 and a GF Value™ of $26.44. The stock has 2 warning signs investors should review.

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

BML's operating assets for the quarter that ended in Mar. 2026 was $726.1 Mil. BML's operating liabilities for the quarter that ended in Mar. 2026 was $291.8 Mil. BML's Total Assets for the quarter that ended in Dec. 2025 was $1,134.3 Mil. Therefore, BML's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2026 was 0.38.


BML Scaled Net Operating Assets Historical Data

* Premium members only.

The historical data trend for BML's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BML Scaled Net Operating Assets Chart

BML Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Scaled Net Operating Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.22 0.22 0.32 0.42 0.35

BML Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Scaled Net Operating Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.42 0.38 0.36 0.38 0.38

BMLKF vs TMO, DHR, IDXX: Scaled Net Operating Assets Comparison

For the Diagnostics & Research subindustry, BML's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BML Scaled Net Operating Assets vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, BML's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where BML's Scaled Net Operating Assets falls into.


BMLKF
73GF Score
BML Inc BMLKF
Scaled Net Operating Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BML Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

BML's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Mar. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(A: Mar. 2026 )
=(Operating Assets (A: Mar. 2026 )-Operating Liabilities (A: Mar. 2026 ))/Total Assets (A: Mar. 2025 )
=(726.09-291.809)/1226.861
=0.35

where

Operating Assets(A: Mar. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=1154.801 - 428.711
=726.09

Operating Liabilities(A: Mar. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=322.159 - 19.977 - 10.373
=291.809

BML's Scaled Net Operating Assets (SNOA) for the quarter that ended in Mar. 2026 is calculated as

Scaled Net Operating Assets (SNOA)(Q: Mar. 2026 )
=(Operating Assets (Q: Mar. 2026 )-Operating Liabilities (Q: Mar. 2026 ))/Total Assets (Q: Dec. 2025 )
=(726.09-291.809)/1134.336
=0.38

where

Operating Assets(Q: Mar. 2026 )
=Total Assets - Cash, Cash Equivalents, Marketable Securities
=1154.801 - 428.711
=726.09

Operating Liabilities(Q: Mar. 2026 )
=Total Liabilities - Long-Term Debt & Capital Lease Obligation - Short-Term Debt & Capital Lease Obligation
=322.159 - 19.977 - 10.373
=291.809

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Scaled Net Operating Assets of 0.38 mean?
BML (BMLKF) has a Scaled Net Operating Assets of 0.38 as of Mar. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on BML and its competitors.
Is BML's Scaled Net Operating Assets too high?
BML's current Scaled Net Operating Assets is 0.38. Overall, BML has a GF Score™ of 73/100, reflecting its overall financial health beyond just this single metric.
How does BML's Scaled Net Operating Assets compare to TMO and DHR?
BML's Scaled Net Operating Assets of 0.38 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Medical Diagnostics & Research company?
A good Scaled Net Operating Assets depends on the Medical Diagnostics & Research industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on BML and its competitors. BML's current Scaled Net Operating Assets is 0.38. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BML stock overvalued right now?
BML (BMLKF) has a current Scaled Net Operating Assets of 0.38. The stock's GF Value™ is $26.44, compared to a current price of $25.21 — trading 4.7% below its estimated fair value. The current Scaled Net Operating Assets is 0.38. BML's overall GF Score™ is 73/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For BML (BMLKF), the current Scaled Net Operating Assets is 0.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BML (BMLKF) Overvalued in 2026?

Based on GuruFocus' analysis, BML stock appears to be undervalued. The current stock price of $25.21 is trading 4.7% below its estimated GF Value™ of $26.44.

Key valuation signals for BMLKF:

  • Scaled Net Operating Assets: 0.38
  • GF Value™: $26.44 vs. price of $25.21 (4.7% below fair value)
  • GF Score™: 73/100 with 2 warning signs

No single metric tells the full story. See the BMLKF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


BML Business Description

Other Exchanges 4694:Japan
Address 5-21-3 Sendagaya, Shibuya-ku, Tokyo, JPN, 1510051
BML Inc provides laboratory testing services in Japan through a network of regional facilities. Its core clinical testing business provides a range of general and specialty laboratory tests, as well as microbiological tests that can be used for applications like food sanitation and environmental analysis. BML often uses automated systems to process and analyze these test samples. In addition to its clinical testing business, BML also has a medical information systems business and a genome-related business. The medical information systems business provides electronic medical charts and information systems that can be used in conjunction with its laboratory tests. The genome business provides gene analysis services.
73GF Score

Get the complete analysis for BMLKF

Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$25.21
Price
$26.44
GF Value